Homepage / Programme Live /

Semaglutide -GLP 1 receptor agonist as an adjunct therapy to biopsychosocial care model for effective management of severe obesity and its complications in children and young persons (CYP) - is it safe and effective therapy? - (P-219)

Talk details

Poster Corner 4 FRIDAY: Childhood Obesity and Type 2 Diabetes
Childhood Obesity and Type 2 Diabetes
Semaglutide -GLP 1 receptor agonist as an adjunct therapy to biopsychosocial care model for effective management of severe obesity and its complications in children and young persons (CYP) - is it safe and effective therapy? (P-219)
A. GUPTA
07/11/2025 15:15 - 16:15 CEST